Company Filing History:
Years Active: 2022-2024
Title: Dale Bredesen: Innovator in Alzheimer's Research
Introduction
Dale Bredesen is a prominent inventor and researcher based in Culver City, CA. He has made significant contributions to the field of Alzheimer's disease research, focusing on innovative pharmaceutical compounds that target tau proteins. With a total of 2 patents, Bredesen's work is paving the way for new treatments in neurodegenerative diseases.
Latest Patents
Bredesen's latest patents include the development of triazolopyridines and triazolopyrimidines that lower stress-induced p-tau. These pharmaceutical compounds, compositions, methods, and uses are designed to inhibit or reduce the phosphorylation of tau proteins. Additionally, they act as antagonists of corticotropin-releasing factor. This innovative approach aims to treat or prevent symptoms of Alzheimer's disease by targeting the phosphorylation of tau proteins.
Career Highlights
Dale Bredesen has established himself as a leading figure in Alzheimer's research. His work at Nantneuro, LLC has been instrumental in advancing the understanding of neurodegenerative diseases. Bredesen's research is characterized by a commitment to developing effective treatments that address the underlying mechanisms of Alzheimer's disease.
Collaborations
Bredesen collaborates with notable colleagues, including Varghese John and Patricia R Spilman. Their combined expertise enhances the research efforts at Nantneuro, LLC, contributing to the development of innovative solutions for Alzheimer's disease.
Conclusion
Dale Bredesen's contributions to Alzheimer's research through his patents and collaborative efforts highlight his dedication to finding effective treatments for neurodegenerative diseases. His innovative work continues to inspire advancements in the field.